Simmons Bank Sells 32 Shares of Colgate-Palmolive (CL)

Simmons Bank decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,461 shares of the company’s stock after selling 32 shares during the quarter. Simmons Bank’s holdings in Colgate-Palmolive were worth $775,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of CL. American Beacon Advisors Inc. acquired a new position in Colgate-Palmolive in the 1st quarter worth $102,000. Proficio Capital Partners LLC raised its stake in shares of Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after purchasing an additional 207 shares in the last quarter. OLD Second National Bank of Aurora bought a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at about $109,000. Harbour Capital Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter valued at about $121,000. Finally, Hanson & Doremus Investment Management grew its position in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after buying an additional 70 shares during the last quarter. Institutional investors and hedge funds own 72.96% of the company’s stock.

Colgate-Palmolive (NYSE CL) opened at $74.59 on Wednesday. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. The stock has a market cap of $65,436.40, a P/E ratio of 25.97, a PEG ratio of 3.41 and a beta of 0.81. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.73. The business had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the firm posted $0.73 earnings per share. analysts anticipate that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.15%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

CL has been the subject of a number of recent research reports. Jefferies Group reaffirmed a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Macquarie started coverage on shares of Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price for the company. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, September 20th. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $75.00 to $84.00 in a research report on Monday, September 25th. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $76.04.

In other news, insider Victoria L. Dolan sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the transaction, the insider now directly owns 60,528 shares in the company, valued at $4,422,780.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Justin Skala sold 126,393 shares of the stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the completion of the transaction, the chief operating officer now owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The disclosure for this sale can be found here. Insiders sold 173,673 shares of company stock valued at $12,629,293 over the last quarter. Insiders own 1.02% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Simmons Bank Sells 32 Shares of Colgate-Palmolive (CL)” was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2017/12/06/simmons-bank-sells-32-shares-of-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply